title: Cochrane in context: Rifamycins compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
authors.affiliation: Department of Medicine, All India Institute of Medical Sciences, New Delhi, India. sksharma.aiims@gmail.com.
authors.forename: Surendra K
authors.initials: SK
authors.lastname: Sharma
authors.forename: Tamilarasu
authors.initials: T
authors.lastname: Kadhiravan
authors.forename: Prathap
authors.initials: P
authors.lastname: Tharyan
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D018023:HIV Seronegativity; D006801:Humans; D055985:Latent Tuberculosis / Q000188:drug therapy*; D017828:Rifabutin / Q000627:therapeutic use*; D012293:Rifampin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*
chemical_list: D000904:Antibiotics, Antitubercular; D017828:Rifabutin; D012293:Rifampin
keywords: HIV-negative; isoniazid; latent TB infection; people; rifamycins; tuberculosis